Skip to main content

Precigen, Inc.

PGEN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001356090

In the last 90 days, Precigen, Inc. insiders filed 1 open-market purchase and 9 sales; 210 institutions reported holding it in 13F filings for Q2 2026, worth $799.4M in total; no superinvestor holds it.

Members of Congress who traded PGEN

No member of Congress has reported a trade in Precigen, Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.